News & Analysis on Clinical Trial Services & Contract Research And Development
The pharmaceutical industry had to adapt quickly to the pandemic if it was to continue to supply important medicines, while also racing to develop vaccines and treatments. Supply chains have come under intense pressure, and companies of all kinds have had to adapt to this “new normal” to avoid delays. During this Q&A, Catalent discusses the challenges they faced and solutions they implemented to overcome the daunting challenges during the pandemic.
Paid for and content provided by Catalent
The nature and scope of clinical research has changed significantly over the past decade. Studies are more complex, globalized and patient-centric than ever. Yet, the processes used to package and ship study drugs to trial sites are stuck in an earlier...
With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader area landscape in order to develop a distribution strategy that avoids delays and minimizes cost and...
An optimized approach to comparator sourcing can improve inventory management and supply chain performance. This article summarizes key factors to comparator sourcing success, different comparator sourcing strategies, common pitfalls to avoid, the...
For more product information visit Catalent.